01.03.2019 • NewsDede WillamsNouryon

Nouryon Licenses Fibers Technology to Indonesia

Nouryon Licenses Fibers Technology to Indonesia (c) Nouryon
Nouryon Licenses Fibers Technology to Indonesia (c) Nouryon

Nouryon – the former AkzoNobel Specialty Chemicals – has licensed its carbon disulfide (CS2) manufacturing technology to an unnamed “leading viscose fibers manufacturer” in Indonesia, enabling it to lift output of its plant on the island of Sumatra.

As part of the arrangement, the Dutch company has agreed to market any surplus CS2 volumes produced by the plant.

Nouryon said its CSD technology is being used to produce manmade fibers for products ranging from textiles to tea bags, as well as in agriculture, pharmaceuticals, and mining.

According to Ignacio Garin, general manager Sulfur Derivatives at Nouryon, using the technology the Indonesian plant has been confirmed to produce better than forecasted results.”

Egbert Henstra, managing director Ethylene and Sulfur Derivatives at Nouryon, said such collaborations allow the company to build a global CS2 supply network and simplify its logistics as well as improving customer service to better meet growing demand for CS2 across Asia-Pacific.

Nouryon said it recently made a commercial delivery to a Chinese customer – the first time that CS2 was imported into the People’s Republic.  

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.